Among the authors' findings: "Mitoxantrone, siponimod, and ocrelizumab are superior to other drug options in delaying disease ...

A 57-year-old woman with a 12-h history of fever and severe pain in her back, pelvis, and thighs attended our hospital. 24 h ...

You've got a lot of them, everything from disease-modifying therapies and drugs that help manage symptoms to rehabilitation ...

The disease usually starts as a fibrinous exudation with mycobacteria, polymorphonuclear cells and granuloma formation. The evolution is towards a serosanguineous exudate with lymphocytes ...

Recently, licensed and emerging treatments for metastatic castrate-resistant prostate cancer are transforming the prognosis for men whose disease has already progressed during or after docetaxel ...

尽管近年来有一些新的药物获批用于治疗R/R PTCL，但大多数药物单药疗效有限，仍需探索新的联合治疗策略。西达本胺是我国自主研发的亚型选择性组蛋白去乙酰化抑制剂 (HDACi)，是治疗R/R ...

2024年9月13-17日，2024年欧洲肿瘤内科学会（ESMO）年会于西班牙巴塞罗那正式召开。作为肿瘤领域最具权威的年度盛会之一，本届年会再次云集全球肿瘤大咖、汇聚领域最新进展。